A more accurate patient-facing statement is this: BPC-157 and thymosin beta-4-related compounds are being studied for tissue repair and inflammatory pathways, but patients should approach them with caution, medical supervision, and realistic expectations
In personal communications, the researcher noted that, To our knowledge, GSH is an active substance and metabolized mostly in the small intestine
Lets see if that experiment yields any different result
In this study, we further explored the possible mechanism by which the HGF/c-Met pathway promotes PNI in pancreatic cancer
Optic Labs supplies BPC-157 as a high-purity lyophilised powder in 5mg and 10mg vials, packaged for in vitro and preclinical laboratory research
We will ask about this at consultation and coordinate with your GP where appropriate